RVL Pharmaceuticals plc (RVLP)
Market Open
20 Oct, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 03
-0.01
-32.0482%
$
3.14M Market Cap
- P/E Ratio
- Div Yield
63.96M Volume
0 Eps
$ 0.04
Previous Close Want to track RVLP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RVL Pharmaceuticals plc (RVLP) Statistics
Valuation metrics
Market Cap 3.14M
Enterprise value 16.09M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 0.06
Price/Book (mrq) 0.05
Enterprise Value/Revenue 0.32
Enterprise Value/EBITDA -0.44
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0
52-Week high 1.66
Beta -
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.04%
Operating margin -0.92%
Operational effectiveness
Return on assets -0.4%
Return on equity -0.81%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.55
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.5
Total debt (mrq) -
Total Debt/Equity (mrq) 1.13
Current ratio (mrq) 2.89%
Book value per share (mrq) 0.57
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
